Throughout the forecast period, the worldwide post-traumatic stress disorder treatment market is likely to be driven by an increasing number of inorganic initiatives such as product launches, collaborations, expansion, and partnerships to develop pharmaceuticals for the treatment of post-traumatic stress disorder. Throughout the projected period, the worldwide post-traumatic stress disorder treatment market is predicted to rise due to an increase in the number of product launches and collaboration between major industries participants in the treatment of PTSD. One of the fundamental constraints of the worldwide post-traumatic stress disorder. One of the significant limitations in the worldwide post-traumatic stress disorder treatment market is a lack of information about the pharmaceuticals used to treat post-traumatic stress disorder, such as Sertraline, Paroxetine, and others. Syncope, lightheadedness, diarrhoea, nausea, sweating, dizziness, xerostomia, disorientation, hallucinations, tremor, somnolence, impotency, lethargy, rhinitis, and female sexual dysfunction are the most common adverse effects of sertraline. Sertraline may also increase the risk of bleeding since it inhibits platelet aggregation.
According to Coherent Market Insights, Global Post-Traumatic Stress Disorder Treatment Market is estimated to be valued at US$ 1034.3 million in 2022 and is expected to witness a CAGR of 5.1% over the forecast period (2022 – 2030).
Market Players in the Post-Traumatic Stress Disorder Treatment Industry:
1. Jazz Pharmaceuticals plc.
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. It has licensing and collaboration agreements with Zymeworks Inc.; Sumitomo Pharma Co., Ltd; Werewolf Therapeutics, Inc.; Codiak BioSciences, Inc.; Ligand Pharmaceuticals Incorporated; XL-protein GmbH; and Redx Pharma plc. The company was incorporated in 2003 and is headquartered in Dublin, Ireland. In October 2020, Jazz Pharmaceuticals plc, a pharmaceutical company, and SpringWorks Therapeutics, Inc., a biotechnology company, announced that Jazz Pharmaceuticals Ireland Limited and SpringWorks entered into an asset purchase and exclusive license agreement under which Jazz had acquired SpringWorks' Fatty Acid Amide Hydrolase ("FAAH") inhibitor program including PF-04457845 in US$ 375 million.
2. Allergan PLC
It is Operator of a pharmaceutical company intended to focus on manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products. The company engages in medical aesthetics, eye care, central nervous system and gastroenterology and delivers innovative patient care. The company was founded in 1989, headquartered in Dublin.
3. Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceuticals is a pharmaceutical company that operates throughout the globe. The company was founded in 1989, headquartered in Maryland, U.S.
4. Neurovation Labs, Inc.
It is Operator of a biotechnology company intended to develop post-traumatic stress disorder diagnostics and treatments. The company focuses on diagnosing and treating anxiety disorders specializing in post-traumatic stress disorders, helping doctors and medical staff to diagnose and treat mental health disorders. The company was founded in 2016, headquartered in New York.
5. Eli Lilly and Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
6. GlaxoSmithKline PLC
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
7. Bristol-Myers Squibb
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company was founded in 1887 and is headquartered in New York, New York.
8. Johnson and Johnson
Johnson & Johnson engages in the research and development, manufacture, and sale of a range of products in the healthcare field. The company was founded in 1886, headquartered in New Jersey.
9. Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
10. Aurobindo Inc.
Aurobindo Pharma is a pharmaceuticals company offering generic pharmaceuticals. The company was founded in 1992, headquartered in New Jersey.
11. Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals manufactures, markets and/or distributes more than 88 drugs in the United States. The company was founded in 1995, headquartered in New Jersey.
*Defintion- Post-traumatic stress disorder (PTSD) is a mental health illness that is triggered by a traumatic incident, which can be experienced or observed, such as a natural catastrophe, a major accident, sexual violence, a terrorist attack, and so on. PTSD may affect people of various ages.
